DrugPatentWatch Database Preview
Details for Patent: 7,229,613
» See Plans and Pricing
Which drugs does patent 7,229,613 protect, and when does it expire?
Patent 7,229,613 protects WELCHOL and is included in three NDAs.
Protection for WELCHOL has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has sixty-four patent family members in eighteen countries.
Summary for Patent: 7,229,613
Title: | Method for lowering serum glucose |
Abstract: | A method for treating hyperglycemia and/or reducing serum glucose levels in a patient that includes administering to the patient a therapeutically effective amount of an amine polymer is disclosed. In one embodiment, the amine polymer is aliphatic. Examples of polymers useful in an embodiment of the invention include sevelamer hydrogen chloride and colesevelam. The invention includes the use of amine polymers such as a cross-linked polymer characterized by a repeat unit having the formula: ##STR00001## and salts and copolymers thereof, where n is a positive integer and x is zero or an integer between 1 and about 4. Also described is a use, for the manufacture of a medicament, of a polymer that lowers serum glucose. |
Inventor(s): | Burke; Steven K. (Sudbury, MA), Donovan; Joanne M. (Needham, MA) |
Assignee: | Genzyme Corporation (Cambridge, MA) |
Application Number: | 10/125,700 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,229,613
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Daiichi Sankyo Inc | WELCHOL | colesevelam hydrochloride | BAR, CHEWABLE;ORAL | 210895-001 | Apr 3, 2019 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | |||||
Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | FOR SUSPENSION;ORAL | 022362-001 | Oct 2, 2009 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | FOR SUSPENSION;ORAL | 022362-002 | Oct 2, 2009 | AB | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,229,613
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 331525 | Start Trial | |||
Austria | 380553 | Start Trial | |||
Austria | 390927 | Start Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |